Henry Lichenstein

Title: Innovations by Henry Lichenstein in the Treatment of Inflammatory Bowel Disease

Introduction

Henry Lichenstein is an accomplished inventor based in Guilford, CT (US). He has made significant contributions to the field of medical treatments, particularly focusing on inflammatory bowel disease. His innovative approach utilizes growth factor-related polypeptides to address inflammatory conditions in the intestinal tract of mammals.

Latest Patents

Henry Lichenstein holds a patent for "Methods of prevention and treatment of inflammatory bowel disease." This invention is centered around methods for treating inflammatory conditions in the intestinal tract using specific polypeptides. The patent claims methods that aim to reduce mortality rates or delay mortality in subjects suffering from inflammatory pathologies. The invention includes the use of fibroblast growth factor-CX (FGF-CX) polynucleotide sequences and the corresponding polypeptides, as well as methods involving FCTRX polynucleotide sequences and their variants.

Career Highlights

Henry Lichenstein has been associated with Curagen Corporation, where he has contributed to groundbreaking research and development in the medical field. His work has led to advancements in the treatment of inflammatory diseases, showcasing his dedication to improving patient outcomes.

Collaborations

Henry has collaborated with Michael Jeffers, working together to enhance the effectiveness of their research and innovations in the treatment of inflammatory bowel disease.

Conclusion

Henry Lichenstein's innovative work in the treatment of inflammatory bowel disease highlights his commitment to advancing medical science. His patent reflects a significant step forward in addressing serious health conditions, demonstrating the impact of his contributions to the field.